Company / R&D per Share
Outset Medical, Inc. R&D per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$16.23
FY2025
5-year range
$0.55 / $16.23
FY2021-FY2025
Trend
+1572.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share changed +1572% YoY in FY2025, a notable deviation from the 5-year average annual change of +308%.
Based on SEC 10-K filings.
16.23 in FY2025 with a 5-year CAGR of -8.2%.
Improved from $0.76 to $16.23 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +198.4%
- 5-Year CAGR
- -8.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- Outset Medical, Inc.'s r&d per share has grown for 4 consecutive years.
- In FY2025, r&d per share increased 1572.0% year-over-year.
- Peak r&d per share was recorded in FY2020.
- Lowest r&d per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.88 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $16.23 | +1572.0% |
| FY2024 | $0.97 | +28.1% |
| FY2023 | $0.76 | +24.1% |
| FY2022 | $0.61 | +11.8% |
| FY2021 | $0.55 | -97.8% |
| FY2020 | $24.85 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026